109 related articles for article (PubMed ID: 8395148)
1. Molecular immunopathogenesis of myasthenia gravis using MHC class II mutant and transgenic mice.
Shenoy M; David C; Oshima M; Atassi MZ; Christadoss P
Ann N Y Acad Sci; 1993 Jun; 681():329-31. PubMed ID: 8395148
[No Abstract] [Full Text] [Related]
2. Molecular immunopathogenesis of experimental autoimmune myasthenia gravis.
Christadoss P; Shenoy M
Reg Immunol; 1992; 4(5):314-20. PubMed ID: 1337839
[No Abstract] [Full Text] [Related]
3. Immunogenetic mechanisms in myasthenia gravis.
Steinman L
Prog Brain Res; 1990; 84():117-24. PubMed ID: 2267289
[No Abstract] [Full Text] [Related]
4. The role of major histocompatibility complex genes in myasthenia gravis and experimental autoimmune myasthenia gravis pathogenesis.
Kaul R; Shenoy M; Christadoss P
Adv Neuroimmunol; 1994; 4(4):387-402. PubMed ID: 7536602
[No Abstract] [Full Text] [Related]
5. Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis.
Kaul R; Shenoy M; Goluszko E; Christadoss P
J Immunol; 1994 Mar; 152(6):3152-7. PubMed ID: 8144909
[TBL] [Abstract][Full Text] [Related]
6. Clonal anergy of I-E-tolerant T cells in transgenic mice with pancreatic expression of MHC class II I-E.
Burkly LC; Lo D; Kanagawa O; Brinster RL; Flavell RA
Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():815-20. PubMed ID: 2518011
[No Abstract] [Full Text] [Related]
7. Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.
Christadoss P; Lindstrom JM; Talal N; Duvic CR; Kalantri A; Shenoy M
J Immunol; 1986 Sep; 137(6):1845-9. PubMed ID: 2943805
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a mouse model of myasthenia gravis which mimics human myasthenia gravis pathogenesis for immune intervention.
Christadoss P; Kaul R; Shenoy M; Goluszko E
Adv Exp Med Biol; 1995; 383():195-9. PubMed ID: 8644502
[No Abstract] [Full Text] [Related]
9. Genetic control of experimental autoimmune myasthenia gravis in mice. III. Ia molecules mediate cellular immune responsiveness to acetylcholine receptors.
Christadoss P; Lennon VA; Krco CJ; David CS
J Immunol; 1982 Mar; 128(3):1141-4. PubMed ID: 6799570
[TBL] [Abstract][Full Text] [Related]
10. Development of antigen-specific therapies for autoimmune disease.
Steinman L
Mol Biol Med; 1990 Aug; 7(4):333-9. PubMed ID: 2233245
[TBL] [Abstract][Full Text] [Related]
11. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
Infante AJ; Thompson PA; Krolick KA; Wall KA
J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
[TBL] [Abstract][Full Text] [Related]
12. Molecular probing of disease susceptibility genes in myasthenia gravis patients: an analysis of T-cell receptor and HLA class II genes using restriction fragment length polymorphism.
Smith CI; Borgonovo L; Carlsson B; Hammarström L; Rabbitts TH
Ann N Y Acad Sci; 1987; 505():388-97. PubMed ID: 3120635
[No Abstract] [Full Text] [Related]
13. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.
Schwartz RH
Annu Rev Immunol; 1985; 3():237-61. PubMed ID: 2415139
[No Abstract] [Full Text] [Related]
14. The interactions between antigen-presenting cells (APC) and T lymphocytes.
Cohen IR
Ann Immunol (Paris); 1984; 135C(3):400-2. PubMed ID: 6433777
[No Abstract] [Full Text] [Related]
15. Coimmunization of MHC class II competitor peptides during experimental autoimmune myasthenia gravis induction resulted not only in a suppressed, but also in an altered immune response.
Wauben MH; Hoedemaekers AC; Graus YM; Wagenaar JP; Van Eden W; De Baets MH
Ann N Y Acad Sci; 1998 May; 841():338-41. PubMed ID: 9668254
[No Abstract] [Full Text] [Related]
16. Use of peptide: HLA class II complexes to study specific T cells in autoimmune myasthenia gravis.
Kishore U; Zhang W; Corlett L; Waters P; Glaichenhaus N; Willcox N
Ann N Y Acad Sci; 2003 Sep; 998():339-42. PubMed ID: 14592893
[No Abstract] [Full Text] [Related]
17. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
[TBL] [Abstract][Full Text] [Related]
18. Genetic control of autoimmunity to acetylcholine receptors: role of Ia molecules.
Christadoss P; Lennon VA; Krco CJ; Lambert EH; David CS
Ann N Y Acad Sci; 1981; 377():258-77. PubMed ID: 6803646
[TBL] [Abstract][Full Text] [Related]
19. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
20. The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models.
Tournier-Lasserve E; Bach JF
J Neuroimmunol; 1993 Sep; 47(2):103-14. PubMed ID: 8370764
[No Abstract] [Full Text] [Related]
[Next] [New Search]
